Mechanism of specific nuclear transport of adriamycin: The mode of nuclear translocation of adriamycin-proteasome complex

Cancer Research

Volumn 61, Issue 6, 2001, Pages 2467-2471

  Kiyomiya, K I ^a   Matsuo, S ^a   Kurebe, M ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DOXORUBICIN; PROTEASOME;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELLULAR DISTRIBUTION; DRUG TRANSPORT; LEUKEMIA CELL; MELANOMA CELL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOSINE TRIPHOSPHATE; AFFINITY LABELS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; CYSTEINE ENDOPEPTIDASES; DIGITONIN; DOXORUBICIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; LEUKEMIA L1210; MELANOMA, EXPERIMENTAL; MICE; MICROSCOPY, CONFOCAL; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 0035866817     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 3H]doxorubicin after intravenous administration in the mouse
2. Uptake and intracellular distribution of doxorubicin metabolites in B-lymphocytes of chronic lymphocytic leukemia
3. Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nuclear concentration
4. Membrane transport of anthracyclines
5. Proteasome is a carrier to translocate doxorubicin from cytoplasm into nucleus
6. In situ photoaffinity labeling of proteasome with photoactive Adriamycin analogue
7. ATP-dependent proteases in prokaryotic and eukaryotic cells
8. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway
9. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin
10. Proteasomes: Protein degradation machines of the cell
11. Proteasome: From structure to function
12. Changes in proteasome localization during the cell cycle
13. Electron microscopic localization of the multicatalytic proteinase complex in rat liver and in cultured cells
14. Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol
15. Abnormally high expression of proteasomes in human leukemic cells
16. Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells
17. Regulation of gene expression of proteasomes (multi-protease complexes) during growth and differentiation of human hematopoietic cells
18. Changes in intracellular localization of proteasomes in immortalized ovarian granulosa cells during mitosis associated with a role in cell cycle control
19. A high molecular weight protease in the cytosol of rat liver. I. Purification enzymological properties, and tissue distribution
20. Possible mechanism of nuclear translocation of proteasomes
21. Localization of a sequence motif complementary to the nuclear localization signal in proteasomes from Thermoplasma acidophilum by immunoelectron microscopy
22. Nuclear localization signals of human and Thermoplasma proteasomal α subunits are functional in vitro
23. Dynamics of proteasome distribution in living cells
24. Rat heart anthracycline-binding polypeptides identified by photoaffinity labeling
25. The two steps of nuclear import, targeting to the nuclear envelope and translocation through the nuclear pore, require different cytosolic factors
26. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
27. Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7)
28. Confluence dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine mammary cells
29. Reduction of 1-β-D-arabinofuranosylcytosine and Adriamycin cytotoxicity following cell cycle arrest by anguidinc
30. The multicatalytic and 26S proteases
31. Proteasomes: Multicatalytic proteinase complex
32. Direct evidence for nuclear and cytoplasmic colocalization of proteasomes (multiprotease complex) in liver
33. Photoaffinity labeling of biological systems
34. Photoaffinity labels as pharmacological tools
35. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution
36. Proteasome from Thermoplasma acidophilum: A threonine protease
37. The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20S proteasome
38. The nuclear membrane
39. Activation of the cell death program by inhibition of proteasome function
40. Apoptosis induction resulting from proteasome inhibition